STSC looking strong..... Bioneb is main reason I think STSC will do well also......
Diabetes, global epidemic effecting 10% of the worlds population~ a US$548 billion market growing at 11% per annum.Currently no no effective , efficient pulmonary delivery device available. Bio~logics and Bio~simlars ((Exubera) formulations delivered using Bioneb Micron Micro Mesh technology are set to change the delivery of insulin in a safe , convenient and efficient manner.
The real measure of your wealth is how much you’d be worth if you lost all your money.